期刊文献+

益气活血法治疗冠心病经皮冠状动脉介入术术后患者临床观察 被引量:1

Efficacy observation of method of supplementing qi and activating blood circulation on coronary heart disease after percutaneous coronary intervention
下载PDF
导出
摘要 目的:观察益气活血法治疗冠心病(CHD)经皮冠状动脉介入术(PCI)术后患者的临床疗效及安全性。方法:将64例CHD PCI术后患者按治疗方法分为两组各32例。PCI术后,对照组予阿司匹林肠溶片联合替格瑞洛片口服治疗,治疗组在对照组治疗的基础上,予归芎参芪麦味方治疗。两组患者均持续治疗12周以上。比较两组患者的临床疗效。结果:治疗后,治疗组和对照组的总有效率分别为96.88%和65.63%,组间差异有统计学意义(P<0.05);治疗后,治疗组EF、凝血酶原时间及甘油三酯、总胆固醇、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇水平改善均优于对照组,差异有统计学意义(P<0.05)。两组患者治疗期间均未发生药物不良反应。结论:益气活血法治疗冠心病PCI术后患者临床疗效确切,能有效地改善血脂水平,增强心脏功能,且安全性较好。 Objective:To observe the clinical efficacy and safety of method of supplementing qi and activating blood circulation on coronary heart disease(CHD)after percutaneous coronary intervention(PCI).Methods:64 cases of patients with CHD after PCI were divided into two groups according to the treatment methods,32 cases in each group.After PCI,the control group was treated with oral Aspirin Enteric-coated Tablets and Ticagrelor Tablets,while the treatment group was treated with Guixiong Shenqi Maiwei formula on the basis of control group.Both groups were treated continuously for more than 12 weeks.The clinical efficacy were compared between two groups.Results:After treatment,the total effective rates of treatment group and control group were 96.88%and 65.63%respectively,and the difference between groups was statistically significant(P<0.05).After treatment,EF,prothrombin time,triglyceride,total cholesterol,high-density lipoprotein cholesterol and low-density lipoprotein cholesterol of treatment group were significantly improved,which was better than those of control group,and the difference was statistically significant(P<0.05).No adverse drug reaction occurred in both groups during treatment.Conclusion:The method of supplementing qi and activating blood circulation has a definite clinical efficacy on patients with coronary heart disease after PCI.It can effectively improve the level of blood lipids,enhance the cardiac function,and the safety is better.
作者 殷丽茹 熊滔 YIN Li-ru;XIONG Tao(The First Affiliated Hospital of Wannan Medical College,Wuhu 241001,China;不详)
出处 《山西中医》 2023年第1期15-17,共3页 Shanxi Journal of Traditional Chinese Medicine
基金 安徽省中医药传承创新科研项目(编号:皖中医药发展秘[2020]53号)。
关键词 冠心病 经皮冠状动脉介入术 益气活血 归芎参芪麦味方 中医药疗法 coronary heart disease percutaneous coronary intervention supplementing qi and activating blood circulation Guixiong Shenqi Maiwei formula therapy of TCM
  • 相关文献

参考文献4

  • 1无.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2015,43(5):380-393. 被引量:2303
  • 2周仲瑛主编..中医内科学 新世纪第2版[M].北京:中国中医药出版社,2007:521.
  • 3郑筱萸主编..中药新药临床研究指导原则 试行[M].北京:中国医药科技出版社,2002:392.
  • 4朱文锋主编..中医诊断与鉴别诊断学[M].北京:人民卫生出版社,1999:966.

二级参考文献11

共引文献2302

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部